GO:0004747 ribokinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004747 (ribokinase activity) catalyzes the ATP-dependent phosphorylation of D-ribose to D-ribose 5-phosphate, the first committed step in ribose salvage.
• The reaction requires a catalytic Mg2+ ion and is influenced by inorganic phosphate, as shown for bacterial ribokinase and related family members.
• Human ribokinase activity depends on specific residues in the ribose binding site, and mutations there impair catalysis.
• Ribokinase-family enzymes can exhibit broad substrate specificity, including activity toward D-arabinose or myo-inositol, which can be engineered by rational mutagenesis.
• Ribokinase activity is linked to nucleotide metabolism, nucleic acid synthesis, and has been explored as a serodiagnostic target in tuberculosis.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of ribokinase function in health and disease.
Description
Ribokinase activity (GO:0004747) is a molecular function defined as the catalysis of the reaction ATP + D-ribose = ADP + D-ribose 5-phosphate. This phosphorylation event converts free D-ribose into D-ribose 5-phosphate, a central metabolite in the pentose phosphate pathway and a precursor for nucleotide biosynthesis. The enzyme belongs to the ribokinase family, which includes phosphofructokinase-2 and other sugar kinases that share a common catalytic fold and often require divalent metal ions. Because ribose salvage supports nucleic acid synthesis and cellular energy balance, ribokinase activity is of broad interest in microbiology, cancer metabolism, and structural biology. Biochemical studies have shown that bacterial ribokinase is sensitive to inorganic phosphate, which modulates its activity and may reflect a regulatory role in response to phosphate availability. In Escherichia coli, the lid domain of ribokinase can be engineered to alter substrate specificity, achieving an order-of-magnitude increase in activity toward D-arabinose, demonstrating the plasticity of this enzyme family. Structural and mutational analyses of human ribokinase have identified ribose-binding residues that are required for catalytic activity, providing a framework for understanding disease-associated variants. Beyond its canonical role, ribokinase activity has been linked to topoisomerase I in mycobacteria, where physical and functional interactions between D-ribokinase and topoisomerase I have opposite effects on their respective activities. Ribokinase screened from Mycobacterium tuberculosis genomic libraries has also shown potential for serodiagnosis of tuberculosis, highlighting its immunological relevance. In cancer, altered expression of ribokinase activity has been observed in Novikoff hepatoma variants, suggesting a role in tumor metabolism. These findings position GO:0004747 as a functionally significant and experimentally tractable target for gene editing and metabolic research.
ribokinase activity At A Glance
| GO ID | GO:0004747 |
|---|---|
| GO term | ribokinase activity |
| Ontology | molecular_function |
| Synonym | ATP:D-ribose 5-phosphotransferase activity; deoxyribokinase activity; D-ribokinase activity; ribokinase (phosphorylating) |
| Major function | Catalysis of ATP + D-ribose = ADP + D-ribose 5-phosphate |
| Cofactor | Mg2+ (catalytic metal ion) |
| Substrate specificity | D-ribose; can be engineered toward D-arabinose or myo-inositol in family members |
| Regulation | Inorganic phosphate modulates activity |
| Family | Ribokinase family (includes phosphofructokinase-2) |
What Is GO:0004747?
Ribokinase activity (GO:0004747) is the catalytic function that transfers a phosphate group from ATP to D-ribose, yielding ADP and D-ribose 5-phosphate. This reaction is the first step in the ribose salvage pathway and is essential for recycling free ribose into nucleotide metabolism. The term is classified as a molecular_function in the Gene Ontology and includes synonyms such as ATP:D-ribose 5-phosphotransferase activity, deoxyribokinase activity, D-ribokinase activity, and ribokinase (phosphorylating).
Why Is ribokinase activity Important in Cell Biology?
Ribokinase activity is important because it controls the entry of free D-ribose into the pentose phosphate pathway, directly influencing nucleotide synthesis, NADPH production, and cellular redox balance. Its role in nucleotide metabolism makes it relevant to rapidly proliferating cells, including cancer cells, and to pathogens that depend on ribose salvage for survival. Moreover, the ribokinase family is a model system for understanding sugar kinase mechanism, metal ion catalysis, and substrate specificity, with implications for enzyme engineering and drug design.
• Provides D-ribose 5-phosphate for nucleotide and nucleic acid biosynthesis.
• Links ribose salvage to the pentose phosphate pathway and cellular redox homeostasis.
• Altered ribokinase activity is observed in cancer models such as Novikoff hepatoma variants.
• Mycobacterial ribokinase interacts with topoisomerase I, affecting DNA topology and enzyme activity.
• Ribokinase is a potential serodiagnostic antigen for tuberculosis.
• The ribokinase family includes phosphofructokinase-2, connecting sugar phosphorylation to metabolic regulation.
• Catalytic Mg2+ and phosphate sensitivity reveal conserved regulatory mechanisms.
• Substrate specificity can be engineered, enabling biotechnological applications.
• Human ribokinase mutations in the ribose binding site impair activity, relevant to inborn errors of metabolism.
• Ribokinase-family enzymes can phosphorylate alternative sugars such as myo-inositol, expanding metabolic roles.
Molecular Mechanism of ribokinase activity
Substrate binding and catalytic mechanism
In simple terms: Ribokinase grabs D-ribose and ATP, then transfers a phosphate from ATP onto the sugar.
Ribokinase activity catalyzes the transfer of the gamma-phosphate of ATP to the 5-hydroxyl group of D-ribose, producing D-ribose 5-phosphate and ADP. The reaction requires a catalytic Mg2+ ion that coordinates the phosphate groups of ATP and stabilizes the transition state, as demonstrated for the ribokinase family member phosphofructokinase-2. Structural and mutational studies of human ribokinase have identified specific residues in the ribose binding site that are essential for substrate recognition and catalysis; mutation of these residues abolishes or severely reduces activity.
Cofactors and metal ion requirement
In simple terms: A magnesium ion acts like a helper that makes the phosphate transfer possible.
The catalytic activity of ribokinase depends on a divalent metal ion, typically Mg2+, which is coordinated by conserved aspartate residues and the ATP phosphates. In Escherichia coli phosphofructokinase-2, a member of the ribokinase family, evidence for a catalytic Mg2+ ion and the effect of phosphate on activity has been established, highlighting a conserved mechanism across the family. Inorganic phosphate can also modulate ribokinase activity, as shown for bacterial ribokinase, possibly by competing with or stabilizing the active site.
Substrate specificity and engineering
In simple terms: Ribokinase prefers D-ribose, but scientists can change its shape to make it accept other sugars.
Ribokinase is highly specific for D-ribose, but rational mutagenesis in the lid domain of E. coli ribokinase can dramatically alter specificity, yielding an order-of-magnitude increase in activity toward D-arabinose. Similarly, an uncharacterized member of the ribokinase family in Thermococcus kodakarensis exhibits myo-inositol kinase activity, demonstrating that the family can accommodate diverse substrates. These findings underscore the evolutionary and engineering potential of the ribokinase fold.
Regulation by phosphate and interaction partners
In simple terms: Phosphate levels and partner proteins can turn ribokinase activity up or down.
Inorganic phosphate affects the activity of bacterial ribokinase, suggesting a regulatory feedback mechanism linked to phosphate availability. In Mycobacterium smegmatis and Mycobacterium tuberculosis, D-ribokinase physically and functionally interacts with topoisomerase I, with opposite effects on their respective activities, indicating a moonlighting or regulatory role beyond sugar phosphorylation. These interactions may coordinate nucleotide metabolism with DNA topology control.
Role in ribose salvage and nucleotide metabolism
In simple terms: Ribokinase starts the process that recycles ribose into the building blocks of RNA and DNA.
The product of ribokinase activity, D-ribose 5-phosphate, is a precursor for the pentose phosphate pathway and nucleotide biosynthesis. This salvage route is particularly important for cells that cannot synthesize ribose de novo or that require rapid nucleotide production, such as cancer cells and microbial pathogens. In Novikoff hepatoma variants, altered expression of ribokinase activity has been observed, linking this function to tumor metabolism.
Key Genes Involved in GO:0004747 ribokinase activity
The following genes and proteins are directly associated with ribokinase activity (GO:0004747) or its regulation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RBKS (human) | Encodes ribokinase; phosphorylates D-ribose to D-ribose 5-phosphate | Mutations in ribose-binding residues impair activity; target for metabolic studies |
| rbsK (E. coli) | Bacterial ribokinase; catalyzes D-ribose phosphorylation | Model for phosphate regulation and substrate specificity engineering |
| pfkB (E. coli) | Phosphofructokinase-2; ribokinase family member | Evidence for catalytic Mg2+ and phosphate effects |
| TK2284 (T. kodakarensis) | Ribokinase family member with myo-inositol kinase activity | Demonstrates broad substrate tolerance in the family |
| Rv2436c (M. tuberculosis) | D-ribokinase; interacts with topoisomerase I | Potential drug target and serodiagnostic antigen |
| topA (M. tuberculosis) | Topoisomerase I; interacts with D-ribokinase | Functional interaction modulates both activities |
| RBKS (Novikoff hepatoma) | Ribokinase activity variant | Altered expression in hepatoma variants links to cancer metabolism |
| rbsD (E. coli) | Ribose transport and metabolism | Context for ribokinase pathway |
| rbsA (E. coli) | Ribose ABC transporter | Supports ribose uptake for ribokinase |
| rbsB (E. coli) | Ribose-binding periplasmic protein | Ribose sensing and transport |
| rbsC (E. coli) | Ribose transport permease | Membrane component of ribose uptake |
| rbsR (E. coli) | Ribose operon repressor | Regulates ribokinase expression |
| RBKS (human variant) | Ribokinase with altered ribose binding site | Functional analysis of disease-associated mutations |
| PfkB (T. kodakarensis) | Ribokinase family member | Myo-inositol kinase activity expands family functions |
| D-ribokinase (M. smegmatis) | Interacts with topoisomerase I | Regulatory cross-talk in mycobacteria |
| Ribokinase (M. tuberculosis) | Serodiagnostic antigen | Screened from T7 phage library for TB diagnosis |
How Is ribokinase activity Regulated?
Ribokinase activity is regulated at multiple levels. In bacteria, inorganic phosphate modulates enzyme activity, likely reflecting phosphate availability. In E. coli, the ribose operon repressor RbsR controls expression of ribokinase and associated transport genes in response to ribose. In mycobacteria, physical interaction with topoisomerase I affects D-ribokinase activity, suggesting post-translational regulation. Additionally, the catalytic Mg2+ ion is essential for activity, and mutations in the ribose binding site of human ribokinase abolish function, indicating tight structural control.
ribokinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RBKS (human) | Metabolic disorder due to impaired ribose salvage | Knockout or point-mutation in human cell lines |
| RBKS (Novikoff hepatoma) | Cancer metabolism | Overexpression or knockout in hepatoma cell lines |
| Rv2436c (M. tuberculosis) | Tuberculosis pathogenesis and serodiagnosis | Knockout in M. tuberculosis; serological assays |
| topA (M. tuberculosis) | DNA topology and ribokinase interaction | Knockout or point mutation in mycobacteria |
| rbsK (E. coli) | Bacterial ribose metabolism | Knockout and substrate specificity engineering |
Ribokinase activity in cancer metabolism
Altered expression of ribokinase activity has been reported in Novikoff hepatoma variants, suggesting that ribose salvage may be rewired in cancer cells to support rapid nucleotide synthesis. This raises the possibility that ribokinase could be a metabolic vulnerability in certain tumors, though further studies are needed to establish causality.
Ribokinase and tuberculosis
Mycobacterium tuberculosis ribokinase interacts with topoisomerase I, and this interaction has opposite effects on their respective activities, potentially influencing DNA topology and metabolism during infection. Ribokinase screened from M. tuberculosis genomic libraries has shown potential for serodiagnosis of tuberculosis, indicating that the host immune system recognizes this antigen.
Human ribokinase mutations and metabolic disorders
Residues of the ribose binding site are required for human ribokinase activity, and mutations in these residues may lead to loss of function. Although specific diseases linked to RBKS mutations are not yet fully defined in the cited literature, the essential role of ribokinase in ribose salvage suggests that defects could impact nucleotide metabolism and cellular homeostasis.
From ribokinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ribokinase affect nucleotide pools? | RBKS knockout cell lines |
| Do ribose-binding site mutations impair catalysis? | Point-mutation knock-in of RBKS variants |
| Can ribokinase substrate specificity be altered? | Rational mutagenesis in E. coli rbsK |
| Does ribokinase interact with topoisomerase I? | Knock-in of tagged RBKS in mycobacteria |
| Is ribokinase a serodiagnostic antigen? | Overexpression of M. tuberculosis ribokinase for serology |
| Does ribokinase expression correlate with cancer? | Overexpression or knockout in hepatoma variants |
How to Study the ribokinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic coupled assay | Ribokinase activity via ADP production | Kinetic characterization of wild-type and mutant enzymes |
| X-ray crystallography | Three-dimensional structure of ribokinase | Identifying substrate and metal binding sites |
| Site-directed mutagenesis | Effect of specific residues on activity | Mapping catalytic and ribose-binding residues |
| Phage display library screening | Antigen-antibody interactions | Serodiagnosis of tuberculosis |
| CRISPR knockout | Loss-of-function phenotype | Testing metabolic dependence on ribokinase |
| CRISPR point mutation | Effect of disease-associated variants | Modeling human RBKS mutations |
| Overexpression | Gain-of-function and interaction studies | Analyzing ribokinase in cancer or mycobacteria |
| Co-immunoprecipitation | Protein-protein interactions | Detecting ribokinase-topoisomerase I complexes |
Enzymatic assays for ribokinase activity
Ribokinase activity can be measured spectrophotometrically by coupling the production of ADP to NADH oxidation or by using radioactive ATP. Such assays have been used to characterize bacterial ribokinase and its sensitivity to inorganic phosphate. Mutational analysis of human ribokinase has employed similar kinetic assays to determine the impact of ribose-binding site residues.
Structural biology and mutagenesis
X-ray crystallography and site-directed mutagenesis have been used to identify catalytic residues and the Mg2+ binding site in ribokinase family members. Rational mutagenesis in the lid domain of E. coli ribokinase has been guided by structural data to alter substrate specificity.
Screening and serodiagnosis
T7 phage display libraries of M. tuberculosis genomic DNA have been screened to identify ribokinase as a potential serodiagnostic antigen, with ELISA-based validation. This approach combines molecular biology and immunology to detect pathogen-specific antibodies.
Gene editing and functional genomics
CRISPR-Cas9 knockout, point mutation, and knock-in strategies enable precise manipulation of RBKS and related genes in cell lines and model organisms. These methods allow researchers to test the causal role of ribokinase activity in metabolic pathways and disease phenotypes.
How CRISPR Can Be Used to Study GO:0004747 ribokinase activity
Knockout
CRISPR-Cas9 knockout of RBKS or bacterial rbsK eliminates ribokinase activity, allowing researchers to assess its role in ribose salvage, nucleotide pools, and cell growth. Such models are essential for validating metabolic dependencies and for identifying compensatory pathways.
Point Mutation
Point mutations in the ribose binding site of human ribokinase have been shown to impair activity, and CRISPR-mediated introduction of these mutations can model loss-of-function states in isogenic cell lines. This approach is valuable for dissecting the contribution of individual residues to catalysis.
Knock-in
Knock-in of tagged or fluorescently labeled ribokinase enables live-cell imaging and interaction studies, such as tracking the physical interaction between D-ribokinase and topoisomerase I in mycobacteria. Knock-in of disease-associated variants can also model human metabolic disorders.
Overexpression
Overexpression of ribokinase in cancer cell lines or mycobacteria can reveal gain-of-function phenotypes, such as altered proliferation or immune recognition. This strategy is useful for producing recombinant enzyme for biochemical and serological assays.
How EDITGENE Supports ribokinase activity Research
Researchers studying ribokinase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of GO:0004747 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for ribokinase activity research.
Frequently Asked Questions About ribokinase activity
What is ribokinase activity?
Ribokinase activity (GO:0004747) is the catalysis of ATP + D-ribose = ADP + D-ribose 5-phosphate, the first step in ribose salvage.
What genes are involved in ribokinase activity?
Key genes include RBKS in humans, rbsK in E. coli, and Rv2436c in M. tuberculosis, among others.
What is the function of ribokinase?
It phosphorylates D-ribose to D-ribose 5-phosphate, linking ribose salvage to nucleotide biosynthesis.
Does ribokinase require magnesium?
Yes, a catalytic Mg2+ ion is required for activity, as shown for ribokinase family members.
How is ribokinase activity regulated?
It is regulated by inorganic phosphate, expression of the ribose operon, and protein-protein interactions such as with topoisomerase I.
Is ribokinase involved in disease?
Altered ribokinase activity has been observed in cancer models, and mycobacterial ribokinase is a potential TB serodiagnostic antigen.
Can ribokinase substrate specificity be changed?
Yes, rational mutagenesis in the lid domain of E. coli ribokinase increased activity toward D-arabinose by an order of magnitude.
What are the synonyms for ribokinase activity?
Synonyms include ATP:D-ribose 5-phosphotransferase activity, deoxyribokinase activity, D-ribokinase activity, and ribokinase (phosphorylating).
How can I study ribokinase activity in the lab?
Enzymatic assays, structural biology, mutagenesis, and CRISPR-based gene editing are common approaches.
What CRISPR models are available for ribokinase research?
Knockout, point mutation, knock-in, and overexpression models can be generated in various cell types to study ribokinase function.
Conclusion
Ribokinase activity (GO:0004747) is a fundamental enzymatic function that connects ribose salvage to nucleotide metabolism and cellular energy balance. Its conservation across bacteria and humans, coupled with its sensitivity to phosphate and metal ions, makes it a compelling target for mechanistic and translational research. The availability of CRISPR-based models and biochemical assays now allows precise interrogation of ribokinase in cancer, infectious disease, and metabolic disorders. Continued investigation of this enzyme family promises to reveal new insights into sugar kinase biology and potential therapeutic opportunities.
References
- 1. Maj MC et al.. 2001. The effect of inorganic phosphate on the activity of bacterial ribokinase.. J Protein Chem 20(2):139-44 PMID: 11563694
- 2. Jargiello P. 1982. Altered expression of ribokinase activity in Novikoff hepatoma variants.. Biochim Biophys Acta 698(1):78-85 PMID: 6288103
- 3. Ferreira JC et al.. 2025. Residues of the ribose binding site are required for human ribokinase activity.. J Struct Biol X 12:100137 PMID: 41256051
- 4. Sato T et al.. 2013. An uncharacterized member of the ribokinase family in Thermococcus kodakarensis exhibits myo-inositol kinase activity.. J Biol Chem 288(29):20856-20867 PMID: 23737529
- 5. Zayats EA et al.. 2022. Rational Mutagenesis in the Lid Domain of Ribokinase from E. coli Results in an Order of Magnitude Increase in Activity towards D-arabinose.. Int J Mol Sci 23(20) PMID: 36293391
- 6. Parducci RE et al.. 2006. Evidence for a catalytic Mg2+ ion and effect of phosphate on the activity of Escherichia coli phosphofructokinase-2: regulatory properties of a ribokinase family member.. Biochemistry 45(30):9291-9 PMID: 16866375
- 7. Yang Q et al.. 2011. Physical and functional interaction between D-ribokinase and topoisomerase I has opposite effects on their respective activity in Mycobacterium smegmatis and Mycobacterium tuberculosis.. Arch Biochem Biophys 512(2):135-42 PMID: 21683681
- 8. Luo D et al.. 2019. Ribokinase screened from T7 phage displayed Mycobacterium tuberculosis genomic DNA library had good potential for the serodiagnosis of tuberculosis.. Appl Microbiol Biotechnol 103(13):5259-5267 PMID: 31069485
